Ann: Notice under ASX Listing Rule 3.10A, page-21

Well thanks for the investing lesson using the benefit of hindsight. Of course I should have sold when the price was high. Why didn't I think of that? Are you purposefully trying to be obnoxious with these statements?

The mix of sales is turning around because of the shrinking generic sales following the massive purchase of said generic products from Teva. That's no strategic masterplan from management. Just the reality of the situation as they try and unwind the Teva debacle.
I've asked if the Teva purchase has been fully written off yet because that's the only way MYX is going to show a profit. I didn't get a straight answer but according to my analysis it must be awfully close. So I'm crossing my fingers that we may finally see a Net Profit in the next set of results. But I'm not holding my breath.